Cargando…
Design and methods for a Scandinavian pharmacovigilance study of osteonecrosis of the jaw and serious infections among cancer patients treated with antiresorptive agents for the prevention of skeletal-related events
OBJECTIVE: Osteonecrosis of the jaw (ONJ) is a recognized complication of potent antiresorptive therapies, especially at the doses indicated to prevent skeletal complications for cancer patients with bone metastases. This paper describes the rationale and methods for a prospective, post-authorizatio...
Autores principales: | Acquavella, John, Ehrenstein, Vera, Schiødt, Morten, Heide-Jørgensen, Uffe, Kjellman, Anders, Hansen, Svein, Larsson Wexell, Cecilia, Herlofson, Bente Brokstad, Noerholt, Sven Erik, Ma, Haijun, Öhrling, Katarina, Hernandez, Rohini K, Sørensen, Henrik Toft |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4959599/ https://www.ncbi.nlm.nih.gov/pubmed/27499646 http://dx.doi.org/10.2147/CLEP.S107270 |
Ejemplares similares
-
Existing data sources for clinical epidemiology: Scandinavian Cohort for osteonecrosis of the jaw – work in progress and challenges
por: Schiodt, Morten, et al.
Publicado: (2015) -
Osteonecrosis of the jaw and survival of patients with cancer: a nationwide cohort study in Denmark
por: Corraini, Priscila, et al.
Publicado: (2017) -
Efficacy of a high-dose antiresorptive drug holiday to reduce the risk of medication-related osteonecrosis of the jaw (MRONJ): A systematic review
por: Ottesen, Camilla, et al.
Publicado: (2020) -
Treatment of osteonecrosis of the jaw related to bisphosphonates
and other antiresorptive agents
por: Rodriguez-Lozano, Francisco-Javier, et al.
Publicado: (2016) -
Review and Update of the Risk Factors and Prevention of Antiresorptive-Related Osteonecrosis of the Jaw
por: Kim, Ha Young
Publicado: (2021)